mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT03196986 · COMPLETED
Trial details
- NCT number
- NCT03196986
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2019-08-01
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.